MUSK and myasthenia gravis: Significant differences were observed between the three subgroups (anti-MuSK, pooled anti-AChR, and triple seronegative) in terms of gender, current acetylcholinesterase inhibitor use, and current MG Foundation of American (MGFA) classification.